All Headline News
Tuesday, February 24, 2009
Miami, FL (AHN) – The Food and Drug Administration Thursday approved an implantable device that jolts the brain in people with hard-to-treat symptoms of obsessive compulsive disorder.
The device is called the Reclaim DBS, or deep brain stimulation, and is made by Medtronic. It is meant to treat patients with cases of OCD where drugs and psychotherapy has failed.
(ARTICLE CONTINUES BELOW)
Reclaim DBS will likely be available for sale in the middle of this year.
OCD is estimated to affect one in 50 adults in the United States. Medtronic said the Reclaim DBS will likely only be appropriate for use in under 4,000 patients.
This article was posted: Tuesday, February 24, 2009 at 1:01 pm